Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.036648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Sebastian D Santos-Patarroyo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine Mayo Clinic College of Medicine and Science Rocheste…. Hauptthemen laut MEDLINE: Embolism, Endocarditis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Echocardiographic evaluation of vegetations is crucial in infective endocarditis ( IE ). Although several studies have noted a link between larger vegetations and an increased risk of embolization, a more comprehensive evaluation of vegetation characteristics in a contemporary cohort has not been conducted. Our study aimed to define the short‐term risk of symptomatic embolization in patients with IE . Methods and Results The Mayo Clinic IE registry was screened to identify patients from 2015 to 2021 who had undergone transesophageal echocardiography. Multivariable subdistribution hazards regression analysis was used to identify factors associated with the cumulative incidence of symptomatic embolism over 30 days accounting for the competing risk of death. Overall, 779 patients with IE were included, of whom 517 (66.4%) were men, median age was 65.0 ( interquartile range, 52.9–74.8) years, and 89.3% were White. In total, 234 patients had a symptomatic embolic event, a 30‐day cumulative incidence of 30.2%. In multivariable analysis, a highly mobile vegetation was the strongest predictor of embolism ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine Mayo Clinic College of Medicine and Science Rochester MN USA.
- Cardiac Arrhythmia Service, Division of Cardiovascular Medicine, Brigham and Women's Hospital Harvard Medical School Boston MA USA.
- Department of Internal Medicine University of Miami, Jackson Memorial Hospital Miami FL USA.
- Division of Clinical Trials and Biostatistics Mayo Clinic College of Medicine and Science Rochester MN USA.
- Department of Cardiovascular Medicine Mayo Clinic College of Medicine and Science Rochester MN USA.
ORCID-Profile: Sebastian D Santos-Patarroyo, Juan A Quintero-Martinez, Brian D Lahr, Supavit Chesdachai, Hector R Villarraga, Hector I Michelena, Larry M Baddour
Zitieren
APA
Santos-Patarroyo, S. D., Quintero-Martinez, J. A., Lahr, B. D., Chesdachai, S., DeSimone, D. C., Villarraga, H. R., Michelena, H. I., & Baddour, L. M. (2025). Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036648
Vancouver
Santos-Patarroyo SD, Quintero-Martinez JA, Lahr BD, Chesdachai S, DeSimone DC, Villarraga HR, et al. Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036648
BibTeX
@article{SantosPatarroyo2025,
author = {Santos-Patarroyo, Sebastian D and Quintero-Martinez, Juan A and Lahr, Brian D and Chesdachai, Supavit and DeSimone, Daniel C and Villarraga, Hector R and Michelena, Hector I and Baddour, Larry M},
title = {Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.036648}
}
EUVIMED